Author

M. Dharmaratne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. T. Fard· 1 shared C. Anttila· 1 shared C. Bennett· 1 shared D. Amann-Zalcenstein· 1 shared E. Moya· 1 shared G. Mhango· 1 shared G. Mzembe· 1 shared H. Liang· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. T. Fard

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatial analysis of Hofbauer cell transcriptome, distribution and morphology in placentas exposed to Plasmodium falciparum

R. Ataide, R. Harding, M. Dharmaratne, Y. Chen, K. Fielding, L. Whitehead, K. Rogers, C. Anttila, L. Ling, P. Hickey, D. Amann-Zalcenstein, E. Moya, G. Mhango, S. Kamiza, L. Randall, , S.-R. Pasricha

The paper examines spatial transcriptomic and proteomic profiles of Hofbauer cells in placentas with and without past Plasmodium falciparum infection, finding no significant differences in HBC features but reduced fetal vessel development in infected placentas.

bioRxiv · Nov 27, 2023 · PreprintImmunology

Redox signaling regulates breast cancer metastasis via HIF1alpha-stimulated EMT dynamics and metabolic reprogramming

Z. Ren, M. Dharmaratne, H. Liang, O. Benard, M. Morales-Gallego, K. Suyama, A. T. Fard, J. C. Mar, M. Prystowsky, L. Norton, R. B. Hazan

This study shows that GPx2 loss in mammary tumors enhances metastasis through HIF1-driven EMT and metabolic changes, identified via scRNA-seq.

bioRxiv · Aug 29, 2022 · PreprintCancer Biology